Surveillance for neoplasia in the pancreas
- PMID: 27938791
- PMCID: PMC5552042
- DOI: 10.1016/j.bpg.2016.10.013
Surveillance for neoplasia in the pancreas
Abstract
Despite its low incidence in the general population, pancreatic cancer is one of the leading causes of cancer-related mortality. Survival greatly depends on operability, but most patients present with unresectable disease. Therefore, there is great interest in the early detection of pancreatic cancer and its precursor lesions by surveillance. Worldwide, several programs have been initiated for individuals at high risk for pancreatic cancer. Their first results suggest that surveillance in high-risk individuals is feasible, but their effectiveness in decreasing mortality remains to be proven. This review will discuss which individuals are eligible for surveillance, which lesions are aimed to be detected, and which surveillance modalities are being used in current clinical practice. Furthermore, it addresses the management of abnormalities found during surveillance and topics for future research.
Keywords: Early detection of cancer; Genetic predisposition to disease; Hereditary; Neoplastic syndromes; Pancreatic cyst; Pancreatic neoplasms.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None.
References
-
- Ervik M, Lam F, Ferlay J, Mery L, Soerjomataram I, Bray F. Cancer today. Lyon, France: International Agency for Research on Cancer; 2016. Available from: http://gco.iarc.fr/today.
-
- American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.
-
- Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
